CKD and ESRD can have unpleasant cutaneous manifestations, including alopecia, but there are several helpful approaches to mitigating hair loss.

If you have hair loss due to alopecia areata, you may consider treatment with corticosteroids, which help reduce inflammation. You can either apply them to your scalp or have them injected into ...

If you have alopecia areata, you are probably no stranger to a roller coaster of emotions. It’s true that this condition isn’t life-threatening and doesn't cause physical pain. But it can ...

Alopecia areata incidence was highest in patients in North America, Southeast Asia, and Australia, as well as in women and those aged 30 to 34 years.

This exciting colloquium was spearheaded by the Cicatricial Alopecia Research Foundation (C.A.R.F.). In this article, clinical aspects of six of the more common types of primary cicatricial ...

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.

For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...

placebo in adults with severe alopecia areata, according to phase 3 data presented ... and all were considered unrelated to treatment except for a case of stage 3 follicular lymphoma in the ...

A third JAK candidate – Sun Pharma’s deuruxolitinib– is also in late-stage trials in alopecia areata and was due to be filed for approval in the US in the first half of this year.

HealthDay News — For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8mg is efficacious and tolerable, according to a study ...

Brittany Craiglow, MD, FAAD, analyzed the promising use of baricitinib for severe pediatric alopecia areata. She highlighted late-breaking data from the BRAVE-AA-PEDS study (NCT05723198 ...